# METAXALONE
> **ANDA207466** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2017-08-31
## Drug
- **FDA Application Number:** ANDA207466
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METAXALONE
- **Generic name:** METAXALONE
- **Active ingredients:** METAXALONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** BluePoint Laboratories
- **First approval:** 2017-08-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207466)
---
*AI Analytics · CC0 1.0*